Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
Erratum for: Nature. 2020 Oct;586(7830):589-593. PMID: 33469216.
In the print version of this Article, some of the symbols were corrupted in Fig. 4. The HTML and PDF versions of the Article were correct, and so the original Article has not been corrected online.
Mulligan, Mark J.; Lyke, Kirsten E.; Kitchin, Nicholas; Absalon, Judith; Gurtman, Alejandra; Lockhart, Stephen; Neuzil, Kathleen; Raabe, Vanessa; Bailey, Ruth; Swanson, Kena A.; Li, Ping; Koury, Kenneth; Kalina, Warren; Cooper, David; Fontes-Garfias, Camila; Shi, Pei Yong; Türeci, Özlem; Tompkins, Kristin R.; Walsh, Edward E.; Frenck, Robert; Falsey, Ann R.; Dormitzer, Philip R.; Gruber, William C.; Şahin, Uğur; and Jansen, Kathrin U., "Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults" (2021). Rochester Regional Health authored publications and proceedings. 178.